Chimeric OspA genes, proteins and methods of use thereof

Crowe, Brian A.; Livey, Ian; O'Rourke, Maria; Schwendinger, Michael; Dunn, John J.; Luft, Benjamin J.

Advanced Search OptionsAdvanced Search queries use a traditional Term Search. For more info, see our FAQ.

All Fields:

Patent Title:

Abstract:

Assignee:

Inventor(s):

Patent Number:

Patent Classification (CPC):

More Options ...

Title: Chimeric OspA genes, proteins and methods of use thereof

Abstract

The invention relates to the development of chimeric OspA molecules for use in a new Lyme vaccine. More specifically, the chimeric OspA molecules comprise the proximal portion from one OspA serotype, together with the distal portion from another OspA serotype, while retaining antigenic properties of both of the parent polypeptides. The chimeric OspA molecules are delivered alone or in combination to provide protection against a variety of Borrelia genospecies. The invention also provides methods for administering the chimeric OspA molecules to a subject in the prevention and treatment of Lyme disease or borreliosis.

Inventors:: Crowe, Brian A.; Livey, Ian; O'Rourke, Maria; Schwendinger, Michael; Dunn, John J.; Luft, Benjamin J.

Issue Date:: 2018-02-20

Research Org.:: Research Foundation of the State University of New York, Amherst, NY; Brookhaven National Laboratory (BNL), Upton, NY (United States)

Sponsoring Org.:: USDOE

OSTI Identifier:: 1422826

Patent Number(s):: 9895434

Application Number:: 15/049,438

Assignee:: Brookhaven Science Associates, LLC (Upton, NY)

Patent Classifications (CPCs):: A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES

A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

Show more

A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
A61K2039/575 - {humoral response}
A61K2039/6018 - {Lipids, e.g. in lipopeptides}
A61K2039/70 - {Multivalent vaccine}
A61K39/0225 - {Spirochetes, e.g. Treponema, Leptospira, Borrelia}

A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/04 - Antibacterial agents
A61P31/14 - for RNA viruses
A61P33/00 - Antiparasitic agents
A61P33/14 - Ectoparasiticides, e.g. scabicides
A61P37/04 - Immunostimulants
A61P43/00 - Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES
C07K14/20 - from Spirochaetales

Y - NEW / CROSS SECTIONAL TECHNOLOGIES Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
Y02A50/30 - Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Show less

DOE Contract Number:: DE-SC0012704

Resource Type:: Patent

Resource Relation:: Patent File Date: 2016 Feb 22

Country of Publication:: United States

Language:: English

Subject:: 59 BASIC BIOLOGICAL SCIENCES

Citation Formats


                    Crowe, Brian A., Livey, Ian, O'Rourke, Maria, Schwendinger, Michael, Dunn, John J., and Luft, Benjamin J. Chimeric OspA genes, proteins and methods of use thereof.  United States: N. p., 2018. 
        Web.

Copy to clipboard


                    Crowe, Brian A., Livey, Ian, O'Rourke, Maria, Schwendinger, Michael, Dunn, John J., & Luft, Benjamin J. Chimeric OspA genes, proteins and methods of use thereof.  United States.

Copy to clipboard


                    Crowe, Brian A., Livey, Ian, O'Rourke, Maria, Schwendinger, Michael, Dunn, John J., and Luft, Benjamin J. Tue .  
        "Chimeric OspA genes, proteins and methods of use thereof".  United States.  https://www.osti.gov/servlets/purl/1422826.

Copy to clipboard


                    
@article{osti_1422826,

  title        = {Chimeric OspA genes, proteins and methods of use thereof},

  author       = {Crowe, Brian A. and Livey, Ian and O'Rourke, Maria and Schwendinger, Michael and Dunn, John J. and Luft, Benjamin J.},

  abstractNote = {The invention relates to the development of chimeric OspA molecules for use in a new Lyme vaccine. More specifically, the chimeric OspA molecules comprise the proximal portion from one OspA serotype, together with the distal portion from another OspA serotype, while retaining antigenic properties of both of the parent polypeptides. The chimeric OspA molecules are delivered alone or in combination to provide protection against a variety of Borrelia genospecies. The invention also provides methods for administering the chimeric OspA molecules to a subject in the prevention and treatment of Lyme disease or borreliosis.},

  doi          = {},

  journal      = {},
number       = ,

  volume       = ,

  place        = {United States},

  year         = {2018},

  month        = {2}

}

Copy to clipboard

Patent:

Save / Share:

Export Metadata

Save to My Library

Works referenced in this record:

Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
patent, January 2004

Lobet, Yves; Simon, Markus; Schaible, Ulrich E.
US Patent Document 6,676,942
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6676942

Gene Synthesis[New Synthetic Methods(77)]
journal, June 1989

Engels, Joachim W.; Uhlmann, Eugen
Angewandte Chemie International Edition in English, Vol. 28, Issue 6, p. 716-734
https://doi.org/10.1002/anie.198907161

Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab
journal, April 1997

Li, H.; Dunn, J. J.; Luft, B. J.
Proceedings of the National Academy of Sciences, Vol. 94, Issue 8, p. 3584-3589
https://doi.org/10.1073/pnas.94.8.3584

Reshaping human antibodies: grafting an antilysozyme activity
journal, March 1988

Verhoeyen, M.; Milstein, C.; Winter, G.
Science, Vol. 239, Issue 4847, p. 1534-1536
https://doi.org/10.1126/science.2451287

Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi
journal, April 1989

Bergström, S.; Bundoc, V. G.; Barbour, A. G.
Molecular Microbiology, Vol. 3, Issue 4, p. 479-486
https://doi.org/10.1111/j.1365-2958.1989.tb00194.x

Recombinant constructs of Borrelia burgdorferi
patent, March 2006

Dattwyler, Raymond J.; Gomes-Solecki, Maria; Luft, Benjamin J.
US Patent Document 7,008,625
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7008625

Structure-based Design of a Second-generation Lyme Disease Vaccine Based on a C-terminal Fragment of Borrelia burgdorferi OspA
journal, July 2005

Koide, Shohei; Yang, Xiaohua; Huang, Xiaolin
Journal of Molecular Biology, Vol. 350, Issue 2, p. 290-299
https://doi.org/10.1016/j.jmb.2005.04.066

[14] Protein biotinylation
book, January 1990

Bayer, Edward A.; Wilchek, Meir
Avidin-Biotin Technology, p. 138-160
https://doi.org/10.1016/0076-6879(90)84268-L

Novel pharmaceutically active N-(2-aminoacylamido-2-deoxy-hexosyl)-amides, -carbamates and -ureas
patent, August 1989

Lockhoff, Oswald; Hayauchi, Yutaka; Stadler, Peter
US Patent Document 4,855,283
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/4855283

Effects of amino acid sequence changes on antibody-antigen interactions
journal, January 1994

Colman, P. M.
Research in Immunology, Vol. 145, Issue 1, p. 33-36
https://doi.org/10.1016/S0923-2494(94)80039-1

Borrelia antigen
patent, November 1997

Bergstrom, Sven; Barbour, Alan G.
US Patent Document 5,688,512
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/5688512

Method of making a projection viewable transparency comprising an electrostatographic toner image
patent, August 1993

Aslam, Muhammed; Light, William A.
US Patent Document 5,234,784
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/5234784

Use of deoxyinosine-containing primers vs degenerate primers for polymerase chain reaction based on ambiguous sequence information
journal, April 1994

Rossolini, Gian Maria; Cresti, Stefania; Ingianni, Angela
Molecular and Cellular Probes, Vol. 8, Issue 2, p. 91-98
https://doi.org/10.1006/mcpr.1994.1013

Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis
journal, July 1998

Gross, Dawn M.; Forsthuber, Thomas; Tary-Lehmann, Magdalena
Science, Vol. 281, Issue 5377, p. 703-706
https://doi.org/10.1126/science.281.5377.703

Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes
journal, May 1986

Studier, F. William; Moffatt, Barbara A.
Journal of Molecular Biology, Vol. 189, Issue 1, p. 113-130
https://doi.org/10.1016/0022-2836(86)90385-2

Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor
journal, August 2000

Frankel, Arthur E.; Ramage, Jason; Kiser, Melanie
Protein Engineering, Design and Selection, Vol. 13, Issue 8, p. 575-581
https://doi.org/10.1093/protein/13.8.575

Genetic Analysis of Protein Stability and Function
journal, December 1989

Pakula, A. A.; Sauer, R. T.
Annual Review of Genetics, Vol. 23, Issue 1, p. 289-310
https://doi.org/10.1146/annurev.ge.23.120189.001445

Analysis of the Lipidated Recombinant Outer Surface Protein A fromBorrelia burgdorferiby Mass Spectrometry
journal, March 1997

Bouchon, Bernadette; Klein, Michèle; Bischoff, Rainer
Analytical Biochemistry, Vol. 246, Issue 1, p. 52-61
https://doi.org/10.1006/abio.1996.9982

Enhanced Production of Recombinant Mycobacterium tuberculosis Antigens in Escherichia coli by Replacement of Low-Usage Codons
journal, January 2000

Lakey, D. L.; Voladri, R. K. R.; Edwards, K. M.
Infection and Immunity, Vol. 68, Issue 1, p. 233-238
https://doi.org/10.1128/IAI.68.1.233-238.2000

Using Codon Usage to Predict Genes Origin: Is the Escherichia coli Outer Membrane a Patchwork of Products from Different Genomes?
journal, January 1997

Guerdoux-Jamet, Pascale; Hénaut, Alain; Nitschké, Patrick
DNA Research, Vol. 4, Issue 4, p. 257-265
https://doi.org/10.1093/dnares/4.4.257

From genes to protein structure and function: novel applications of computational approaches in the genomic era
journal, January 2000

Skolnick, Jeffrey; Fetrow, Jacquelyn S.
Trends in Biotechnology, Vol. 18, Issue 1, p. 34-39
https://doi.org/10.1016/S0167-7799(99)01398-0

Antibodies that react with predetermined sites on proteins
journal, February 1983

Sutcliffe, J.; Shinnick, T.; Green, N
Science, Vol. 219, Issue 4585, p. 660-666
https://doi.org/10.1126/science.6186024

Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
patent, October 1989

Berger, Frank; Bona, Constantin; Lechevalier, Mary P.
US Patent Document 4,877,612
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/4877612

Prodrugs of Peptides and Proteins for Improved Formulation and Delivery
journal, April 1993

Oliyai, Reza; Stella, Valentino J.
Annual Review of Pharmacology and Toxicology, Vol. 33, Issue 1, p. 521-544
https://doi.org/10.1146/annurev.pa.33.040193.002513

Improved tools for biological sequence comparison.
journal, April 1988

Pearson, W. R.; Lipman, D. J.
Proceedings of the National Academy of Sciences, Vol. 85, Issue 8, p. 2444-2448
https://doi.org/10.1073/pnas.85.8.2444

Borrelia antigen
patent, July 2000

Bergstrom, Sven; Barbour, Alan G.; Magnarelli, Louis A.
US Patent Document 6,083,722
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6083722

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
journal, September 1979

Towbin, H.; Staehelin, T.; Gordon, J.
Proceedings of the National Academy of Sciences, Vol. 76, Issue 9, p. 4350-4354
https://doi.org/10.1073/pnas.76.9.4350

Strategies for Delivery of Peptides Utilizing Absorption-Enhancing Agents
journal, December 1996

Fix, Joseph A.
Journal of Pharmaceutical Sciences, Vol. 85, Issue 12, p. 1282-1285
https://doi.org/10.1021/js960158a

Recombinant immunoglobin preparations
patent, March 1989

Cabilly, Shmuel; Heyneker, Herbert L.; Holmes, William E.
US Patent Document 4,816,567
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/4816567

Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA.
journal, January 1993

Erdile, L. F.; Brandt, M. A.; Warakomski, D. J.
Infection and Immunity, Vol. 61, Issue 1
https://doi.org/10.1128/IAI.61.1.81-90.1993

An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis.
journal, January 1993

Wilske, B.; Preac-Mursic, V.; Göbel, U. B.
Journal of Clinical Microbiology, Vol. 31, Issue 2
https://doi.org/10.1128/JCM.31.2.340-350.1993

Compositions and methods for administering Borrelia burgdorferi antigens
patent, August 2006

Barbour, Alan G.; Luke, Catherine J.
US Patent Document 7,094,391
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7094391

Enhanced evolutionary PCR using oligonucleotides with inosine at the 3′-terminus
journal, January 1991

Batzer, Mark A.; Carlton, James E.; Deininger, Prescott L.
Nucleic Acids Research, Vol. 19, Issue 18, p. 5081-5081
https://doi.org/10.1093/nar/19.18.5081

A new technique for the assay of infectivity of human adenovirus 5 DNA
journal, April 1973

Graham, F. L.; van der Eb, A. J.
Virology, Vol. 52, Issue 2, p. 456-467
https://doi.org/10.1016/0042-6822(73)90341-3

Safety and Immunogenicity of a Recombinant Outer Surface Protein A Lyme Vaccine
journal, June 1994

Keller, David; Koster, Frederick T.; Marks, Donald H.
JAMA: The Journal of the American Medical Association, Vol. 271, Issue 22, p. 1764-1768
https://doi.org/10.1001/jama.1994.03510460056033

Purification of Borrelia burgdorferi outer surface protein A (OspA) and analysis of antibody binding domains.
journal, January 1994

Jiang, W.; Gorevic, P. D.; Dattwyler, R. J.
Clinical and diagnostic laboratory immunology, Vol. 1, Issue 4
https://doi.org/10.1128/CDLI.1.4.406-412.1994

Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi.
journal, January 1997

Golde, W. T.; Piesman, J.; Dolan, M. C.
Infection and immunity, Vol. 65, Issue 3
https://doi.org/10.1128/IAI.65.3.882-889.1997

Borrelia burdorferi Osp A and B proteins and immunogenic peptides
patent, November 2000

Barbour, Alan G.; Bergstrom, Sven; Hansson, Lennart
US Patent Document 6,143,872
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6143872

Altered ospa of borrelia burgdorferi
patent-application, December 2009

Luft, Benjamin J.; Dunn, John J.; Koide, Shohei
US Patent Document 12/313443; 20090326200
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20090326200

By-passing immunisation
journal, September 1992

Hoogenboom, Hennie R.; Winter, Greg
Journal of Molecular Biology, Vol. 227, Issue 2, p. 381-388
https://doi.org/10.1016/0022-2836(92)90894-P

Reshaping human antibodies for therapy
journal, March 1988

Riechmann, Lutz; Clark, Michael; Waldmann, Herman
Nature, Vol. 332, Issue 6162, p. 323-327
https://doi.org/10.1038/332323a0

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.
journal, November 1984

Morrison, S. L.; Johnson, M. J.; Herzenberg, L. A.
Proceedings of the National Academy of Sciences, Vol. 81, Issue 21, p. 6851-6855
https://doi.org/10.1073/pnas.81.21.6851

Approaches toward the Directed Design of a Vaccine against Borrelia burgdorferi
journal, February 2002

Luft, Benjamin J.; Dunn, John J.; Lawson, Catherine L.
The Journal of Infectious Diseases, Vol. 185, Issue s1, p. S46-S51
https://doi.org/10.1086/338463

A Vaccine Consisting of Recombinant Borrelia burgdorferi Outer-Surface Protein A to Prevent Lyme Disease
journal, July 1998

Sigal, Leonard H.; Zahradnik, John M.; Lavin, Philip
New England Journal of Medicine, Vol. 339, Issue 4, p. 216-222
https://doi.org/10.1056/NEJM199807233390402

Vaccination against Lyme Disease with Recombinant Borrelia burgdorferi Outer-Surface Lipoprotein A with Adjuvant
journal, July 1998

Steere, Allen C.; Sikand, Vijay K.; Meurice, François
New England Journal of Medicine, Vol. 339, Issue 4, p. 209-215
https://doi.org/10.1056/NEJM199807233390401

By-passing immunization: Human antibodies from V-gene libraries displayed on phage
journal, December 1991

Marks, James D.; Hoogenboom, Hennie R.; Bonnert, Timothy P.
Journal of Molecular Biology, Vol. 222, Issue 3, p. 581-597
https://doi.org/10.1016/0022-2836(91)90498-U

Continuous cultures of fused cells secreting antibody of predefined specificity
journal, August 1975

Köhler, G.; Milstein, C.
Nature, Vol. 256, Issue 5517, p. 495-497
https://doi.org/10.1038/256495a0

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
journal, July 1963

Merrifield, R. B.
Journal of the American Chemical Society, Vol. 85, Issue 14, p. 2149-2154
https://doi.org/10.1021/ja00897a025

Preparation and use of polyethylene glycol propionaldehyde
patent, October 1993

Harris, J. Milton; Sedaghat-Herati, M. R.
US Patent Document 5,252,714
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/5252714

Basic local alignment search tool
journal, October 1990

Altschul, Stephen F.; Gish, Warren; Miller, Webb
Journal of Molecular Biology, Vol. 215, Issue 3, p. 403-410
https://doi.org/10.1016/S0022-2836(05)80360-2

Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
journal, January 1996

de Silva, A. M.; Telford, S. R.; Brunet, L. R.
Journal of Experimental Medicine, Vol. 183, Issue 1, p. 271-275
https://doi.org/10.1084/jem.183.1.271

A general method applicable to the search for similarities in the amino acid sequence of two proteins
journal, March 1970

Needleman, Saul B.; Wunsch, Christian D.
Journal of Molecular Biology, Vol. 48, Issue 3, p. 443-453
https://doi.org/10.1016/0022-2836(70)90057-4

OspA DNA and lyme disease vaccine
patent, February 2001

Bergstrom, Sven; Barbour, Alan G.; Magnarelli, Louis A.
US Patent Document 6,183,986
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6183986

Comparison of biosequences
journal, December 1981

Smith, Temple F.; Waterman, Michael S.
Advances in Applied Mathematics, Vol. 2, Issue 4, p. 482-489
https://doi.org/10.1016/0196-8858(81)90046-4

Induction of CD8⁺ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs
journal, April 1990

Takahashi, Hidemi; Takeshfta, Toshiyuki; Morein, Bror
Nature, Vol. 344, Issue 6269, p. 873-875
https://doi.org/10.1038/344873a0

The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi
journal, January 1995

Golde, William T.; Burkot, Thomas R.; Piesman, Joseph
Vaccine, Vol. 13, Issue 5, p. 435-441
https://doi.org/10.1016/0264-410X(94)00027-K

Borrelia antigen
patent, March 2001

Bergstrom, Sven; Barbour, Alan G.; Magnarelli, Louis A.
US Patent Document 6,203,798
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6203798

Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.
journal, July 1984

Geysen, H. M.; Meloen, R. H.; Barteling, S. J.
Proceedings of the National Academy of Sciences, Vol. 81, Issue 13, p. 3998-4002
https://doi.org/10.1073/pnas.81.13.3998

Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90
patent, July 1998

Barbour, Alan G.; Bergstrom, Sven; Hansson, Lennart
US Patent Document 5,777,095
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/5777095

General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.
journal, August 1985

Houghten, R. A.
Proceedings of the National Academy of Sciences, Vol. 82, Issue 15, p. 5131-5135
https://doi.org/10.1073/pnas.82.15.5131

Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
patent, August 1999

Lobet, Yves; Simon, Markus; Schaible, Ulrich E.
US Patent Document 5,942,236
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/5942236

Organization of genes encoding two outer membrane proteins of the Lyme disease agent Borrelia burgdorferi within a single transcriptional unit.
journal, January 1986

Howe, T. R.; LaQuier, F. W.; Barbour, A. G.
Infection and Immunity, Vol. 54, Issue 1
https://doi.org/10.1128/IAI.54.1.207-212.1986

Non-immunogenic polypeptides
patent, December 1979

Davis, Frank F.; Van Es, Theodorus; Palczuk, Nicholas C.
US Patent Document 4,179,337
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/4179337

Replacing the complementarity-determining regions in a human antibody with those from a mouse
journal, May 1986

Jones, Peter T.; Dear, Paul H.; Foote, Jefferson
Nature, Vol. 321, Issue 6069, p. 522-525
https://doi.org/10.1038/321522a0

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults
journal, December 1996

Van Hoecke, C.; Comberbach, M.; De Grave, D.
Vaccine, Vol. 14, Issue 17-18, p. 1620-1626
https://doi.org/10.1016/S0264-410X(96)00146-6

Expression of tetanus toxin fragment C in E.coli : high level expression by removing rare codons
journal, January 1989

Makoff, A. J.; Oxer, M. D.; Romanos, M. A.
Nucleic Acids Research, Vol. 17, Issue 24, p. 10191-10202
https://doi.org/10.1093/nar/17.24.10191

Immunometric assays using monoclonal antibodies
patent, March 1983

David, Gary S.; Greene, Howard E.
US Patent Document 4,376,110
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/4376110

Humanized immunoglobulins
patent, December 1997

Queen, Cary L.; Co, Man Sung; Schneider, William P.
US Patent Document 5,693,762
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/5693762

Structural identification of a key protective B-cell epitope in lyme disease antigen OspA
journal, October 2000

Ding, Wei; Huang, Xiaolin; Yang, Xiaohua
Journal of Molecular Biology, Vol. 302, Issue 5, p. 1153-1164
https://doi.org/10.1006/jmbi.2000.4119

Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection.
journal, January 1995

Lovrich, S. D.; Callister, S. M.; DuChateau, B. K.
Infection and immunity, Vol. 63, Issue 6
https://doi.org/10.1128/IAI.63.6.2113-2119.1995

SV40 DNA transfection of cells in suspension: analysis of the efficiency of transcription and translation of T-antigen
journal, March 1981

Chu, Gilbert; Sharp, Phillip A.
Gene, Vol. 13, Issue 2, p. 197-202
https://doi.org/10.1016/0378-1119(81)90008-1

Inhibition of Borrelia burgdorferi-Tick Interactions In Vivo by Outer Surface Protein A Antibody
journal, June 2001

Pal, U.; Montgomery, R. R.; Lusitani, D.
The Journal of Immunology, Vol. 166, Issue 12, p. 7398-7403
https://doi.org/10.4049/jimmunol.166.12.7398

A comprehensive set of sequence analysis programs for the VAX
journal, January 1984

Devereux, John; Haeberli, Paul; Smithies, Oliver
Nucleic Acids Research, Vol. 12, Issue 1, p. 387-395
https://doi.org/10.1093/nar/12.1Part1.387

Sequence analysis of ospA genes shows homogeneity within Borrelia burgdorferi sensu stricto and Borrelia afzelii strains but reveals major subgroups within the Borrelia garinii species
journal, August 1995

Will, G.; Jauris-Heipke, S.; Schwab, E.
Medical Microbiology and Immunology, Vol. 184, Issue 2, p. 73-80
https://doi.org/10.1007/BF00221390

Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii
journal, October 1997

Gern, Lise; Hu, Chang Min; Voet, Pierre
Vaccine, Vol. 15, Issue 14, p. 1551-1557
https://doi.org/10.1016/S0264-410X(97)00066-2

Amino acid substitution matrices from protein blocks.
journal, November 1992

Henikoff, S.; Henikoff, J. G.
Proceedings of the National Academy of Sciences, Vol. 89, Issue 22, p. 10915-10919
https://doi.org/10.1073/pnas.89.22.10915

Chimeric proteins comprising borrelia polypeptides and uses therefor
patent, June 2001

Dunn, John J.; Luft, Benjamin J.
US Patent Document 6,248,562
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6248562

Applications and statistics for multiple high-scoring segments in molecular sequences.
journal, June 1993

Karlin, S.; Altschul, S. F.
Proceedings of the National Academy of Sciences, Vol. 90, Issue 12, p. 5873-5877
https://doi.org/10.1073/pnas.90.12.5873

Humanized immunoglobulins
patent, December 1996

Queen, Cary L.; Selick, Harold E.
US Patent Document 5,585,089
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/5585089

Similar Records in DOE Patents and OSTI.GOV collections:

Chimeric OspA genes, proteins and methods of use thereof

Patent Crowe, Brian A.; Livey, Ian; O'Rourke, Maria; ...

The invention relates to the development of chimeric OspA molecules for use in a new Lyme vaccine. More specifically, the chimeric OspA molecules comprise the proximal portion from one OspA serotype, together with the distal portion from another OspA serotype, while retaining antigenic properties of both of the parent polypeptides. The chimeric OspA molecules are delivered alone or in combination to provide protection against a variety of Borrelia genospecies. The invention also provides methods for administering the chimeric OspA molecules to a subject in the prevention and treatment of Lyme disease or borreliosis.
Full Text Available
Divinyl ether synthase gene and protein, and uses thereof

Patent Howe, Gregg A [East Lansing, MI]; Itoh, Aya [Tsuruoka, JP]

The present invention relates to divinyl ether synthase genes, proteins, and methods of their use. The present invention encompasses both native and recombinant wild-type forms of the synthase, as well as mutants and variant forms, some of which possess altered characteristics relative to the wild-type synthase. The present invention also relates to methods of using divinyl ether synthase genes and proteins, including in their expression in transgenic organisms and in the production of divinyl ether fatty acids, and to methods of suing divinyl ether fatty acids, including in the protection of plants from pathogens.
Full Text Available
Photoreactive synthetic regulator of protein function and methods of use thereof

Patent Trauner, Dirk; Isacoff, Ehud Y; Kramer, Richard H; ...

The present disclosure provides a photoreactive synthetic regulator of protein function. The present disclosure further provides a light-regulated polypeptide that includes a subject synthetic regulator. Also provided are cells and membranes comprising a subject light-regulated polypeptide. The present disclosure further provides methods of modulating protein function, involving use of light.
Full Text Available
Surface enhanced Raman gene probe and methods thereof

Patent Vo-Dinh, Tuan [Knoxville, TN]

The subject invention disclosed herein is a new gene probe biosensor and methods thereof based on surface enhanced Raman scattering (SERS) label detection. The SER gene probe biosensor comprises a support means, a SER gene probe having at least one oligonucleotide strand labeled with at least one SERS label, and a SERS active substrate disposed on the support means and having at least one of the SER gene probes adsorbed thereon. Biotargets such as bacterial and viral DNA, RNA and PNA are detected using a SER gene probe via hybridization to oligonucleotide strands complementary to the SER gene probe. Themore » « less
Full Text Available
Advanced surface-enhanced Raman gene probe systems and methods thereof

Patent Vo-Dinh, Tuan [Knoxville, TN]

The subject invention is a series of methods and systems for using the Surface-Enhanced Raman (SER)-labeled Gene Probe for hybridization, detection and identification of SER-labeled hybridized target oligonucleotide material comprising the steps of immobilizing SER-labeled hybridized target oligonucleotide material on a support means, wherein the SER-labeled hybridized target oligonucleotide material comprise a SER label attached either to a target oligonucleotide of unknown sequence or to a gene probe of known sequence complementary to the target oligonucleotide sequence, the SER label is unique for the target oligonucleotide strands of a particular sequence wherein the SER-labeled oligonucleotide is hybridized to its complementarymore » « less
Full Text Available

Similar Records

Title: Chimeric OspA genes, proteins and methods of use thereof

Abstract

Citation Formats

Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines patent, January 2004

Gene Synthesis[New Synthetic Methods(77)] journal, June 1989

Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab journal, April 1997

Reshaping human antibodies: grafting an antilysozyme activity journal, March 1988

Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi journal, April 1989

Recombinant constructs of Borrelia burgdorferi patent, March 2006

Structure-based Design of a Second-generation Lyme Disease Vaccine Based on a C-terminal Fragment of Borrelia burgdorferi OspA journal, July 2005

[14] Protein biotinylation book, January 1990

Novel pharmaceutically active N-(2-aminoacylamido-2-deoxy-hexosyl)-amides, -carbamates and -ureas patent, August 1989

Effects of amino acid sequence changes on antibody-antigen interactions journal, January 1994

Borrelia antigen patent, November 1997

Method of making a projection viewable transparency comprising an electrostatographic toner image patent, August 1993

Use of deoxyinosine-containing primers vs degenerate primers for polymerase chain reaction based on ambiguous sequence information journal, April 1994

Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis journal, July 1998

Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes journal, May 1986

Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor journal, August 2000

Genetic Analysis of Protein Stability and Function journal, December 1989

Analysis of the Lipidated Recombinant Outer Surface Protein A fromBorrelia burgdorferiby Mass Spectrometry journal, March 1997

Enhanced Production of Recombinant Mycobacterium tuberculosis Antigens in Escherichia coli by Replacement of Low-Usage Codons journal, January 2000

Using Codon Usage to Predict Genes Origin: Is the Escherichia coli Outer Membrane a Patchwork of Products from Different Genomes? journal, January 1997

From genes to protein structure and function: novel applications of computational approaches in the genomic era journal, January 2000

Antibodies that react with predetermined sites on proteins journal, February 1983

Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process patent, October 1989

Prodrugs of Peptides and Proteins for Improved Formulation and Delivery journal, April 1993

Improved tools for biological sequence comparison. journal, April 1988

Borrelia antigen patent, July 2000

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. journal, September 1979

Strategies for Delivery of Peptides Utilizing Absorption-Enhancing Agents journal, December 1996

Recombinant immunoglobin preparations patent, March 1989

Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. journal, January 1993

An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis. journal, January 1993

Compositions and methods for administering Borrelia burgdorferi antigens patent, August 2006

Enhanced evolutionary PCR using oligonucleotides with inosine at the 3′-terminus journal, January 1991

A new technique for the assay of infectivity of human adenovirus 5 DNA journal, April 1973

Safety and Immunogenicity of a Recombinant Outer Surface Protein A Lyme Vaccine journal, June 1994

Purification of Borrelia burgdorferi outer surface protein A (OspA) and analysis of antibody binding domains. journal, January 1994

Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi. journal, January 1997

Borrelia burdorferi Osp A and B proteins and immunogenic peptides patent, November 2000

Altered ospa of borrelia burgdorferi patent-application, December 2009

By-passing immunisation journal, September 1992

Reshaping human antibodies for therapy journal, March 1988

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. journal, November 1984

Approaches toward the Directed Design of a Vaccine against Borrelia burgdorferi journal, February 2002

A Vaccine Consisting of Recombinant Borrelia burgdorferi Outer-Surface Protein A to Prevent Lyme Disease journal, July 1998

Vaccination against Lyme Disease with Recombinant Borrelia burgdorferi Outer-Surface Lipoprotein A with Adjuvant journal, July 1998

By-passing immunization: Human antibodies from V-gene libraries displayed on phage journal, December 1991

Continuous cultures of fused cells secreting antibody of predefined specificity journal, August 1975

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide journal, July 1963

Preparation and use of polyethylene glycol propionaldehyde patent, October 1993

Basic local alignment search tool journal, October 1990

Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. journal, January 1996

A general method applicable to the search for similarities in the amino acid sequence of two proteins journal, March 1970

OspA DNA and lyme disease vaccine patent, February 2001

Comparison of biosequences journal, December 1981

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs journal, April 1990

The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi journal, January 1995

Borrelia antigen patent, March 2001

Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. journal, July 1984

Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90 patent, July 1998

General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. journal, August 1985

Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines patent, August 1999

Organization of genes encoding two outer membrane proteins of the Lyme disease agent Borrelia burgdorferi within a single transcriptional unit. journal, January 1986

Non-immunogenic polypeptides patent, December 1979

Replacing the complementarity-determining regions in a human antibody with those from a mouse journal, May 1986

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults journal, December 1996

Expression of tetanus toxin fragment C in E.coli : high level expression by removing rare codons journal, January 1989

Immunometric assays using monoclonal antibodies patent, March 1983

Humanized immunoglobulins patent, December 1997

Structural identification of a key protective B-cell epitope in lyme disease antigen OspA journal, October 2000

Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection. journal, January 1995

SV40 DNA transfection of cells in suspension: analysis of the efficiency of transcription and translation of T-antigen journal, March 1981

Inhibition of Borrelia burgdorferi-Tick Interactions In Vivo by Outer Surface Protein A Antibody journal, June 2001

A comprehensive set of sequence analysis programs for the VAX journal, January 1984

Sequence analysis of ospA genes shows homogeneity within Borrelia burgdorferi sensu stricto and Borrelia afzelii strains but reveals major subgroups within the Borrelia garinii species journal, August 1995

Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii journal, October 1997

Amino acid substitution matrices from protein blocks. journal, November 1992

Chimeric proteins comprising borrelia polypeptides and uses therefor patent, June 2001

Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
patent, January 2004

Gene Synthesis[New Synthetic Methods(77)]
journal, June 1989

Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab
journal, April 1997

Reshaping human antibodies: grafting an antilysozyme activity
journal, March 1988

Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi
journal, April 1989

Recombinant constructs of Borrelia burgdorferi
patent, March 2006

Structure-based Design of a Second-generation Lyme Disease Vaccine Based on a C-terminal Fragment of Borrelia burgdorferi OspA
journal, July 2005

[14] Protein biotinylation
book, January 1990

Novel pharmaceutically active N-(2-aminoacylamido-2-deoxy-hexosyl)-amides, -carbamates and -ureas
patent, August 1989

Effects of amino acid sequence changes on antibody-antigen interactions
journal, January 1994

Borrelia antigen
patent, November 1997

Method of making a projection viewable transparency comprising an electrostatographic toner image
patent, August 1993

Use of deoxyinosine-containing primers vs degenerate primers for polymerase chain reaction based on ambiguous sequence information
journal, April 1994

Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis
journal, July 1998

Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes
journal, May 1986

Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor
journal, August 2000

Genetic Analysis of Protein Stability and Function
journal, December 1989

Analysis of the Lipidated Recombinant Outer Surface Protein A fromBorrelia burgdorferiby Mass Spectrometry
journal, March 1997

Enhanced Production of Recombinant Mycobacterium tuberculosis Antigens in Escherichia coli by Replacement of Low-Usage Codons
journal, January 2000

Using Codon Usage to Predict Genes Origin: Is the Escherichia coli Outer Membrane a Patchwork of Products from Different Genomes?
journal, January 1997

From genes to protein structure and function: novel applications of computational approaches in the genomic era
journal, January 2000

Antibodies that react with predetermined sites on proteins
journal, February 1983

Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
patent, October 1989

Prodrugs of Peptides and Proteins for Improved Formulation and Delivery
journal, April 1993

Improved tools for biological sequence comparison.
journal, April 1988

Borrelia antigen
patent, July 2000

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
journal, September 1979

Strategies for Delivery of Peptides Utilizing Absorption-Enhancing Agents
journal, December 1996

Recombinant immunoglobin preparations
patent, March 1989

Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA.
journal, January 1993

An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis.
journal, January 1993

Compositions and methods for administering Borrelia burgdorferi antigens
patent, August 2006

Enhanced evolutionary PCR using oligonucleotides with inosine at the 3′-terminus
journal, January 1991

A new technique for the assay of infectivity of human adenovirus 5 DNA
journal, April 1973

Safety and Immunogenicity of a Recombinant Outer Surface Protein A Lyme Vaccine
journal, June 1994

Purification of Borrelia burgdorferi outer surface protein A (OspA) and analysis of antibody binding domains.
journal, January 1994

Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi.
journal, January 1997

Borrelia burdorferi Osp A and B proteins and immunogenic peptides
patent, November 2000

Altered ospa of borrelia burgdorferi
patent-application, December 2009

By-passing immunisation
journal, September 1992

Reshaping human antibodies for therapy
journal, March 1988

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.
journal, November 1984

Approaches toward the Directed Design of a Vaccine against Borrelia burgdorferi
journal, February 2002

A Vaccine Consisting of Recombinant Borrelia burgdorferi Outer-Surface Protein A to Prevent Lyme Disease
journal, July 1998

Vaccination against Lyme Disease with Recombinant Borrelia burgdorferi Outer-Surface Lipoprotein A with Adjuvant
journal, July 1998

By-passing immunization: Human antibodies from V-gene libraries displayed on phage
journal, December 1991

Continuous cultures of fused cells secreting antibody of predefined specificity
journal, August 1975

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
journal, July 1963

Preparation and use of polyethylene glycol propionaldehyde
patent, October 1993

Basic local alignment search tool
journal, October 1990

Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
journal, January 1996

A general method applicable to the search for similarities in the amino acid sequence of two proteins
journal, March 1970

OspA DNA and lyme disease vaccine
patent, February 2001

Comparison of biosequences
journal, December 1981

Induction of CD8⁺ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs
journal, April 1990

The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi
journal, January 1995

Borrelia antigen
patent, March 2001

Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.
journal, July 1984

Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90
patent, July 1998

General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.
journal, August 1985

Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
patent, August 1999

Organization of genes encoding two outer membrane proteins of the Lyme disease agent Borrelia burgdorferi within a single transcriptional unit.
journal, January 1986

Non-immunogenic polypeptides
patent, December 1979

Replacing the complementarity-determining regions in a human antibody with those from a mouse
journal, May 1986

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults
journal, December 1996

Expression of tetanus toxin fragment C in E.coli : high level expression by removing rare codons
journal, January 1989

Immunometric assays using monoclonal antibodies
patent, March 1983

Humanized immunoglobulins
patent, December 1997

Structural identification of a key protective B-cell epitope in lyme disease antigen OspA
journal, October 2000

Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection.
journal, January 1995

SV40 DNA transfection of cells in suspension: analysis of the efficiency of transcription and translation of T-antigen
journal, March 1981

Inhibition of Borrelia burgdorferi-Tick Interactions In Vivo by Outer Surface Protein A Antibody
journal, June 2001

A comprehensive set of sequence analysis programs for the VAX
journal, January 1984

Sequence analysis of ospA genes shows homogeneity within Borrelia burgdorferi sensu stricto and Borrelia afzelii strains but reveals major subgroups within the Borrelia garinii species
journal, August 1995

Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii
journal, October 1997

Amino acid substitution matrices from protein blocks.
journal, November 1992

Chimeric proteins comprising borrelia polypeptides and uses therefor
patent, June 2001

Applications and statistics for multiple high-scoring segments in molecular sequences.
journal, June 1993

Humanized immunoglobulins
patent, December 1996